![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Corporate information
Registration country
Company type
Discovers and commercializes novel antibody based drugs and drug targets for the major mental and neuro-degenerative diseasesFunding rounds
Series B
( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
MPM Capital | Initial investment. | ||
|
Prospect Venture Partners | Venture capital firm | Initial investment. | |
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Schroder Ventures Life Sciences Inc | Initial investment. | ||
|
Essex Woodlands Health Ventures Inc | Follow-on investment. | ||
|
|
Technology Partners. | Venture capital firm | Follow-on investment. |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
Essex Woodlands Health Ventures Inc | Initial investment. | ||
|
|
Technology Partners. | Venture capital firm | Initial investment. |
Investment activity status
Active investor